Recent news on Sevelamer

Genzyme Reports Significant Revenue and Earnings Growth in First ...  -  Apr 25, 2007
WebWire (press release),Within the Renal business, sales of Renagel® (sevelamer hydrochloride) grew 16 percent to $137.4 million, up from $118.7 million in the first quarter a year

Genzyme Reports Significant Revenue and Earnings Growth in First ...  -  26 Apr 2007
WebWire (press release),Within the Renal business, sales of Renagel® (sevelamer hydrochloride) grew 16 percent to $137.4 million, up from $118.7 million in the first quarter a year

Genzyme completes study on Sevelamer Carbonate in patients with ...  -  Apr 18, 2007
News-Medical.net,Genzyme has announced that a recently completed study of Renvela (sevelamer carbonate) achieved its primary endpoint, demonstrating a statistically

Genzyme Announces Successful Completion of Study Investigating ...  -  Apr 17, 2007
Oxfordshire Bioscience Network (press release),The drug was well tolerated with a safety profile consistent with the clinical experience of patients on dialysis using Renagel® (sevelamer hydrochloride).

Genzyme Announces Successful Completion of Study Investigating ...  -  Apr 18, 2007
Financial News USA (press release),...(Nasdaq: GENZ) recently announced that a recently completed study of Renvela(TM) (sevelamer carbonate) achieved its primary endpoint, demonstrating a

Genzyme Announces Successful Completion of Study Investigating ...  -  Apr 16, 2007
PipelineReview.com (press release),Announced today that a recently completed study of Renvela(TM) (sevelamer carbonate) achieved its primary endpoint, demonstrating a statistically

Genzyme Reports Successful Completion Of Study Investigating ...  -  Apr 16, 2007
Trading Markets,...(GENZ | charts | news | PowerRating) announced that a recently completed study of Renvela (sevelamer carbonate) achieved its primary endpoint,

Genzyme successfully...  -  Apr 16, 2007
Boston Globe,In today's statement, Genzyme announced that it had recently completed a successful study of Renvela, the brand name for sevelamer carbonate.

Market Report -- In Play (GENZ)  -  Apr 16, 2007
MSN MoneyGenzyme announces successful completion of study investigating sevelamer carbonate in patients with chronic kidney disease Co announces a recently completed

Genzyme finishes Renvela study in CKD patients  -  Apr 17, 2007
Renal Business Today,...—Genzyme Corp. said today that it has completed a study of Renvela (sevelamer carbonate), which showed a statistically significant reduction of serum

Genzyme posts strong financials, despite AnorMed charges  -  Feb 15, 2007
Pharma Times (subscription),Another strong contribution to turnover came from Renagel (sevelamer HCl), which treats end-stage kidney disease and was up 22% to $135.1 million.

Genzyme Reports Financial Results for Fourth Quarter of 2006 and ...  -  Feb 14, 2007
WebWire (press release),Sales of Renagel® (sevelamer hydrochloride), a phosphate binder for patients with end-stage renal disease on hemodialysis, are expected to reach $580-$590

Genzyme Files for Approval of Sevelamer Carbonate for Patients on ...  -  Jan 4, 2007
Oxfordshire Bioscience Network (press release),...(Nasdaq: GENZ) announced today that it has filed a New Drug Application (NDA) with the US Food and Drug Administration seeking approval of sevelamer

Genzyme Files for Approval of Sevelamer Carbonate for Patients on ...  -  Dec 21, 2006
PharmaLive.com (press release),Renvela is being developed as a next generation phosphate binder to replace Renagel(R) (sevelamer hydrochloride), the most-prescribed phosphate binder in

Genzyme files for FDA approval of new phosphate binder  -  Dec 21, 2006
Renal Business Today,Genzyme Corp. said today it has filed a New Drug Application with the US Food and Drug Administration for its sevelamer carbonate to be used in chronic

Genzyme applies for kidney drug approval  -  Dec 21, 2006
Boston Globe,The plan is to market sevelamer carbonate under the trade name of Renvela, Genzyme said. One of Genzyme's best selling drugs is Renagel, which prevents

Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude ...  -  Jan 10, 2007
Oxfordshire Bioscience Network (press release),Within the Renal business, Genzyme markets Renagel® (sevelamer hydrochloride), a phosphate binder for patients with end-stage renal disease on hemodialysis,

Genzyme seeks approval for new kidney treatment  -  Dec 21, 2006
Boston Business Journal,Genz) announced on Thursday that it has filed a new drug application with the US Food and Drug Administration seeking approval of Sevelamer carbonate.

Renagel in New Dialysis Study Published in Kidney International  -  Jan 15, 2007
DG NewsThe US-based National Kidney Foundation's 2003 K/DOQI guidelines for Bone Metabolism and Disease in Chronic Kidney Disease recommend sevelamer hydrochloride

(PRN) - Digilab Inc. Reaches Milestone in Biomarker Study in Lung ...  -  Dec 21, 2006
Bolsamania.com,...(PRN) - Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis ... [+]. (PRN) - Global Payments Introduces Mobile Transaction Processing

CV Therapeutics Seeks Europe's OK of Angina Drug and Genzyme Seeks ...  -  26 Dec 2006
Financial News USA (press release),Genz) announced on Thursday that it has filed a new drug application with the US Food and Drug Administration seeking approval of Sevelamer carbonate.

Genzyme Files For Approval Of Sevelamer Carbonate For Patients On ...  -  Dec 23, 2006
Medical News Today (press release),...(Nasdaq: GENZ) announced today that it has filed a New Drug Application (NDA) with the US Food and Drug Administration seeking approval of sevelamer

Genzyme Files for Approval of Sevelamer Carbonate for Patients on ...  -  Dec 21, 2006
PharmaLive.com (press release),Renvela is being developed as a next generation phosphate binder to replace Renagel(R) (sevelamer hydrochloride), the most-prescribed phosphate binder in

Genzyme files for FDA approval of new phosphate binder  -  Dec 21, 2006
Renal Business Today,Genzyme Corp. said today it has filed a New Drug Application with the US Food and Drug Administration for its sevelamer carbonate to be used in chronic

Genzyme applies for kidney drug approval  -  Dec 21, 2006
Boston Globe,The plan is to market sevelamer carbonate under the trade name of Renvela, Genzyme said. One of Genzyme's best selling drugs is Renagel, which prevents

Genzyme seeks approval for new kidney treatment  -  Dec 21, 2006
Boston Business Journal,Genz) announced on Thursday that it has filed a new drug application with the US Food and Drug Administration seeking approval of Sevelamer carbonate.

Water conservation work brings award for firm  -  Dec 5, 2006
Cambridge Evening News,In Genzyme's first entry into these awards, the company was also highly recommended for Best Process Plant in relation to its manufacture of sevelamer

(PRN) - Digilab Inc. Reaches Milestone in Biomarker Study in Lung ...  -  Dec 21, 2006
Bolsamania.com,...(PRN) - Genzyme Files for Approval of Sevelamer Carbonate for Patients on Dialysis ... [+]. (PRN) - Global Payments Introduces Mobile Transaction Processing

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional